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Changes of Serum Fibroblast Growth Factor 21 Level in Acute Myocardial
Infarction Patients
Wenduo Zhang1
1Beijing Hospital, China
BACKGROUND High levels of FGF-21 are founded in CHD patients.
OBJECTIVE However, the changes of plasma levels of FGF-21 in acute
myocardial infarction patients in unknown. To explore characteristics
of FGF-21 in patients with AMI, we measured the serum concentra-
tions of FGF-21 in 100 Chinese subjects (include 45non-AMI and
55AMI) and analyzed its association with a cluster of metabolic pa-
rameters and clinical end points.
METHODS 55 patients with acute myocardial infarction and 45 pa-
tients without acute myocardial infarction were enrolled. Serum
fasting blood glucose, BNP, CK, CK-MB and TNT total cholesterol,
HDL-c, LDL-c, and triglycerides were measured in all patients, Serum
FGF21 of the 1st day, 3rd day, 7th day from the onset of syndrome
were determined. All AMI patients was followed by 30days.
RESULTS The subjects with AMI (n ¼ 55) showed signiﬁcantly higher
serum FGF21 than those without AMI (0.14 (0.11-0.20) vs. 0.25 (0.16-
0.34), P < 0.001), Their FGF21 levels peaked approximately in 24 h
after the onset of AMI and remained high for 7 days. FGF21 were
identiﬁed as an independent factors associated with AMI (odds ratio ¼
1.432, 95% conﬁdence interval: 1.06-1.951., P ¼ 0.003).CONCLUSION High levels of FGF-21 are signiﬁcantly higher in AMI
patients and associated with adverse events. The paradoxical increase
of serum FGF-21 in CHD patients may indicate a compensatory
response or resistance to FGF-21.TCTAP A-006
Clinical Signiﬁcance of ST-Segment Changes in Lead aVR for Patients with
Acute Coronary Syndrome
Zhen Guo Ji1
1The Third Hospital of Shijiazhuang City, China
BACKGROUND Acute occlusion or critical stenosis in the coronary
artery leads to acute coronary syndrome (ACS). Many studies have
shown that ST-segment depression on the admission electrocardio-
gram (ECG) is a strong predictor of poor outcomes in patients with
ACS. ECG changes in the aVR lead may play an important role in the
prognosis of patients with ACS. The aim of our study was to analyze
the prognostic value of the ST-segment changes in aVR in the initial
standard 12-lead ECG performed on admission.
METHODS 446 ACS patients were enrolled and divided into three
groups according to ST-segment changes in aVR: group 1 (ST-segment
no change), group 2 (ST-segment elevation) and group 3 ( ST-segment
depression). The clinical data and global registry of acute coronary
events (GRACE) risk score were compared among three groups.
RESULTS (1) The differences were statistically signiﬁcant among
three groups in the number of previous myocardial infarction, three-
coronary artery lesion and left main lesion (table 1, p<0.05). The in-
cidences were signiﬁcantly higher in ST-segment elevation group than
those in other two groups. (2) GRACE risk scores: The differences were
statistically signiﬁcant among three groups (p<0.05) and further
comparison as follow. Hospital mortality risk score: The scores were
signiﬁcantly higher in ST-segment elevation group than those in ST-
segment no change group (p<0.05). Hospital myocardial infarction
risk score: The scores were signiﬁcantly higher in both ST-segment
elevation and ST-segment depression groups than those no change in
ST-segment group (p<0.05). Mortality risk score of outside hospital
after 6 months: The scores were signiﬁcantly higher in ST-segment
elevation group than both in depression and no change in ST-segment
of aVR groups (p<0.05). Myocardial infarction risk score of outside
hospital after 6 months: The scores were signiﬁcantly higher in ST-
segment elevation than those in ST-segment depression group
(p<0.05).
